Insulet Appoints Ana Maria Chadwick as Chief Financial Officer
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Ana Maria Chadwick has been appointed Executive Vice President, Chief Financial Officer and Treasurer, effective April 22, 2024.
- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Ana Maria Chadwick has been appointed Executive Vice President, Chief Financial Officer and Treasurer, effective April 22, 2024.
- View the full release here: https://www.businesswire.com/news/home/20240320426712/en/
“We are thrilled to welcome Ana to Insulet,” said Jim Hollingshead, President and Chief Executive Officer. - Ana is known for her insight, intellectual agility, and compelling and collaborative leadership.
- Over the span of her career, she has led large and dynamic finance teams, overseeing financial reporting, and driving financial and operational efficiencies in the U.S., Latin America, and Europe.